Greg Piper
Pro-life pregnancy centers are fighting with general democratic prosecutors in court the right to tell women that they can be able to reverse chemical abortions, taking additional progesterone, natural pregnancy hormone, to Prevent mifepriston’s binding with pregnancy receptors. New York Letitia James is trying to overthrow now her order.
Texas Republican Ag Ken Paxton provided a judgment of $ 100,000 against the New York prescription for the prescription of Mifepriston teens for the residents of Texas, who cannot legally get it in the state of Lone Star, but The Lone Star, but the Lone Star, but the lone ancient state, but the lone star state Empire State refused to enforce the judgment according to the law of the shield.
The question remains more fundamental and polarizing: how safe and sound is Mifepriston?
Commissioner for Food and Drug Administration Marta Makara could speak too early when He said Light lights World Summit of the Economy He last week “Lack of plans” limiting mifepriston ending pregnancywhich belongs to Misoprostol to exclude the interrupted fetus, in the featherlight of fresh research on sedate adverse events after chemical abortion.
The “real foot of the world” of these complications after Mifepriston is almost 11%, especially visits to the emergency room (4.73%), hemorrhage (3.31%) and “repeated (surgical) abortion” in order to correct incomplete chemical abortion (2.84%), according to data analysis of “insurance claims” 865.727 Mortone (2.84%), from data analysis.
More than half is described as “other complications specific to abortion” (5.68%), followed by specific conditions: infection (1.34%), hospitalization (0.66%), ectopic pregnancy (0.35%), “other life -threatening adverse events (0.15%) and sepsis (0.10%).
The study was issued on Monday by Center for Ethics and Public Policywho stated that the 11% rate is adapted to some women suffering from many categories of adverse events.
. Restoration of America Foundation I issued my own review of the same data set on Monday, reaching “convergent conclusions” with EPPC reviews, said FFROA spokesman Only a message. However, its findings are less detailed, and the PDF review is dated April 25.
One in 10 women suffering from severe side reactions is a acute contrast with Black-Box FDA warning on Mifepriston – added 20 years ago Three deaths and five sedate, but non -ophy Bacterial infections, for a drug approved only four years earlier – which claims that less than 0.5% of women reported sedate side effects in clinical trials.
The agency did not answer Only a message Questions on Monday about Makary’s answer to fresh research and why he would find it publicly so quickly that he is not planning to change Mifepristone access.
Why not examine the sole?
Just like Louisiana GOP Sen. Bill Cassidy pressed Jaya Bhattacharya In his National Institutes of Health, confirmation so as not to examine any potential relationship between vaccinations and autism, Democratic senators pressed Makary on the audition Excluding scientific research that can change Mifepristone access.
Makary reminded Tammy Baldwin from Wisconsin that FDA used “Strategy for limiting risk assessment” for Mifepriston in 2019.which biden administration updated three times. This requires “continuous data collection, so I can’t rip this data without looking,” he said, such as the hypothetical “interaction with medicines” that would cause a FDA warning.
Baldwin caused Planned parental point of conversation The fact that Mifepriston and Tylenol have similar safety profiles, rejecting Makary’s protest that Tynenol has no REMS.
The Black FDA warning cites studies in which it was found that 2.9-4.6% of women went to ER after Mifepriston, 2-7% of them “will need surgical procedure” because it did not work correctly, and its failure rate is 7% between nine and 10 weeks of pregnancy.
The Democratic Senator New Hampshire, Maggie Hassan, claimed that there was “a lot of data” for the security and effectiveness of Mifepriston and asked if Makary “unilaterally replaced the data that currently exists for political purposes and for political reasons.”
He replied: “I have no pre -accepted plans to make changes to Mifepristone’s policy.”
Makary gave a similar answer to Light lights peak – which The Advisory Council includes the general director of Pfizer Albert Bourla – When PBS News Hour The co -hatch of Amna Nawaz pressed him.
“I have no plans to take action against Mifepristone,” but “I think that as a scientist you must evolve as the data appears,” he said, and if “data suggest something or tell us that there is a real signal, we cannot promise that we will not act on the basis of those data that we have not seen yet.”
Nawaz reacted in disbelief that “decades” of data prove that Mifepriston is “predominantly safe and effective”, asking if Makary would really ignore the “precedent” of earlier data.
He earned Makary’s commitment “without plans” Fast Disapproval from Senator Josh HawleyR-Mo., Which he called it “extremely disappointing.”
Light lights He noticed his wife He argued the challenge for the authority of the FDA loosen the rules of access to mifepriston, including shipping without a personal doctor’s visit, in The Supreme Court, which ruled 9-0, had no legal position last summer.
It is at least extremely disappointing. This is not a good start in the FDA https://t.co/3j5NXTUXW
– Josh Hawley (@hawlyymo) April 24, 2025
Conservative estimation because the database is missing some categories
Ffroa reached Only a message with studies on Monday morning and Susan B. Anthony Pro-Life America Both EPPC and FFROA study two hours later, which caused confusion or they worked together.
Each group of reviews said Only a message Their efforts were not related, but they used the same data, and FFROA said he “ordered the examination.”
SBA PRO-LIFE AMERICA said that the results confirm the arrangements from the Pro-Life Charlotte Lozier Institute, published last year in International Journal of Epidemiology and Public Health Research. Scientists of the Institute sue Sage Publishing based on the law of California withdrawal of an earlier research document with an abortion feather.
EPPC said that his team bought access to the database, which includes “private health insurance, Medicaid, Medicare, Tricare and Department of Veterans Affairs.” The data set “ensures longitudinal tracking of medical diagnoses, procedures and prescriptions for each patient and is widely used in academic and regulatory studies.”
The estimated 11% of the massive side reaction speed is conservative, because the database excludes “transactions for which the insurer is also a supplier (as is the case with some [health maintenance organizations] And many VA care), as well as monetary remuneration transactions (which are disproportionately common in the case of abortion) – said EPPC.
The research was “approved by a team of scientists, analysts and data engineers, with the help of our clinical team of obstetricians and gynecologists certified by the Management Board”, some of which “have the history of academic research and reviewed publication,” says EPPC.
Restoration of which Organization for parents He also has a Political Action Committee and projects regarding voter lamps and “honest courts”, said his “clinical team of gynecologists certified by the management board” has reviewed the database.
Chemical abortions increased from around 92,000 in 2017 to over 154,000 in 2023, a year after returning the states, the Supreme Court to the States, and a sedate indicator of adverse events increased from 9.6% to even 12.2% in 2022,, He found.
California itself was more than half of the chemical abortions in the set of data, which according to FFROA is a quarter of American chemical abortions, based on the estimates of the Guttmacher Institute in the abortion industry. The next majority took place in New York, Illinois, Washington, New Jersey, Minnesota, Maryland and Massachusetts.
None of the research determines who actually checked the data or suggests that the research will be sent to the reviewed publications.
The EPPC spokesman said that the center is not planning to present his research on mutual assessment, but “the methodology is public, and for the data we use, they can access anyone who wants to buy it. We encourage others to replicate our study for themselves.”
He said that it was not “made public by every person who supported this effort for their safety.” The authors are the president of EPPC Ryan Anderson and Director for Data Analysis Jamie Bryan Hall.
“Everyone saw the threats issued towards members of the Supreme Court after Dobbs Decision-said the spokesman. “Other people who assisted in this study are not noisy people with personal safety details, so I think it is understandable why their identity is protected.”
– – –
Greg Piper is only a news reporter.
Photo “Mifepristone” by Robin Marta. CC at 2.0.
